DISEASE SCANNER

Global Incurable Diseases Tracker

Pulmonary Disease

Asthma

MODERATE

Chronic inflammatory airway disease causing reversible bronchospasm, wheezing, dyspnea. Affects 262 million globally. Can be life-threatening during severe attacks.

Global Affected

262.0M

Countries

111

Symptoms

Wheezing

Shortness of breath

Chest tightness

Cough (especially at night)

Difficulty speaking

Anxiety

Rapid breathing

Sweating

Chest pain

Treatment Options

Inhaled corticosteroids

Long-acting beta agonists

Leukotriene modifiers

Biologics

Short-acting bronchodilators

Oral corticosteroids

Bronchial thermoplasty

Risk Factors

1Allergies

2Eczema

3Family history

4Obesity

5Smoking (environmental)

6Air pollution

7Occupational irritants

8Viral infections

9Stress

10GERD

Diagnostic Methods

1Spirometry
2Peak flow monitoring
3FeNO test
4Allergy testing
5Chest X-ray
6CT scan
7Bronchoprovocation test

Prognosis

Good with control; normal life expectancy. Severe asthma: frequent exacerbations, hospitalizations.

Prevention

Avoid triggers
Allergy immunotherapy
Regular exercise
Vaccinations
Smoking avoidance
Air quality improvement

Research Status

Biologics revolutionizing severe asthma (omalizumab, mepolizumab, dupilumab). TSLP inhibitors (tezepelumab) for broad phenotypes.

Sources

https://www.cdc.gov/
https://www.hematology.org/education/patients
https://www.ncbi.nlm.nih.gov/books
https://rarediseases.org/rare-diseases

Medical Disclaimer

This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.